Intervention Review

Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion

  1. Danny Mitry1,*,
  2. Catey Bunce2,
  3. David Charteris1

Editorial Group: Cochrane Eyes and Vision Group

Published Online: 31 JAN 2013

Assessed as up-to-date: 7 AUG 2012

DOI: 10.1002/14651858.CD009510.pub2

How to Cite

Mitry D, Bunce C, Charteris D. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD009510. DOI: 10.1002/14651858.CD009510.pub2.

Author Information

  1. 1

    Moorfields Eye Hospital NHS Foundation Trust, London, UK

  2. 2

    Moorfields Eye Hospital NHS Foundation Trust, Research and Development Department, London, UK

*Danny Mitry, Moorfields Eye Hospital NHS Foundation Trust, City Road, London, EC1V 2PD, UK. mitryd@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 31 JAN 2013

SEARCH

  1. Current Version

    Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion

    Danny Mitry, Catey Bunce and David Charteris

    Article first published online: 31 JAN 2013 | DOI: 10.1002/14651858.CD009510.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion

    Danny Mitry, Catey Bunce and David Charteris

    Article first published online: 7 DEC 2011 | DOI: 10.1002/14651858.CD009510